2437 related articles for article (PubMed ID: 7905099)
1. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours.
Heagerty AH; Fitzgerald D; Smith A; Bowers B; Jones P; Fryer AA; Zhao L; Alldersea J; Strange RC
Lancet; 1994 Jan; 343(8892):266-8. PubMed ID: 7905099
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender.
Heagerty A; Smith A; English J; Lear J; Perkins W; Bowers B; Jones P; Gilford J; Alldersea J; Fryer A; Strange RC
Br J Cancer; 1996 Jan; 73(1):44-8. PubMed ID: 8554981
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients.
Lira MG; Provezza L; Malerba G; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Alaibac M; Turco A; Girolomoni G; Tessari G
Exp Dermatol; 2006 Dec; 15(12):958-65. PubMed ID: 17083362
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma.
Yengi L; Inskip A; Gilford J; Alldersea J; Bailey L; Smith A; Lear JT; Heagerty AH; Bowers B; Hand P; Hayes JD; Jones PW; Strange RC; Fryer AA
Cancer Res; 1996 May; 56(9):1974-7. PubMed ID: 8616834
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis.
Ramsay HM; Harden PN; Reece S; Smith AG; Jones PW; Strange RC; Fryer AA
J Invest Dermatol; 2001 Aug; 117(2):251-5. PubMed ID: 11511301
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients.
Fryer AA; Ramsay HM; Lovatt TJ; Jones PW; Hawley CM; Nicol DL; Strange RC; Harden PN
Carcinogenesis; 2005 Jan; 26(1):185-91. PubMed ID: 15459020
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours.
Ramachandran S; Hoban PR; Ichii-Jones F; Pleasants L; Ali-Osman F; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
Pharmacogenetics; 2000 Aug; 10(6):545-56. PubMed ID: 10975609
[TBL] [Abstract][Full Text] [Related]
8. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?
Dwyer T; Stankovich JM; Blizzard L; FitzGerald LM; Dickinson JL; Reilly A; Williamson J; Ashbolt R; Berwick M; Sale MM
Am J Epidemiol; 2004 May; 159(9):826-33. PubMed ID: 15105175
[TBL] [Abstract][Full Text] [Related]
9. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.
Ramachandran S; Lear JT; Ramsay H; Smith AG; Bowers B; Hutchinson PE; Jones PW; Fryer AA; Strange RC
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):61-7. PubMed ID: 9950241
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma.
Shanley SM; Chenevix-Trench G; Palmer J; Hayward N
Carcinogenesis; 1995 Aug; 16(8):2003-4. PubMed ID: 7634433
[TBL] [Abstract][Full Text] [Related]
11. Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.
Korhonen N; Ylitalo L; Luukkaala T; Itkonen J; Häihälä H; Jernman J; Snellman E; Palve J
Arch Dermatol Res; 2021 Dec; 313(10):879-884. PubMed ID: 32772261
[TBL] [Abstract][Full Text] [Related]
12. [First results on the influence of polymorphisms at glutathione S-transferase, cytochrome P450, and tumor necrosis factor gene loci on the development of multiple head and neck cancer].
Matthias C; Jahnke V; Fryer AA; Strange RC
Laryngorhinootologie; 2003 Jan; 82(1):25-30. PubMed ID: 12548461
[TBL] [Abstract][Full Text] [Related]
13. Absence of association between GSTM1 and GSTT1 polymorphisms and melanoma susceptibility: a meta-analysis.
Nie F; Chen Z; Cao C; Cen Y
DNA Cell Biol; 2011 Oct; 30(10):783-8. PubMed ID: 21563941
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation.
Marshall SE; Bordea C; Haldar NA; Mullighan CG; Wojnarowska F; Morris PJ; Welsh KI
Kidney Int; 2000 Nov; 58(5):2186-93. PubMed ID: 11044240
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype.
Ramachandran S; Fryer AA; Smith AG; Lear JT; Bowers B; Hartland AJ; Whiteside JR; Jones PW; Strange RC
Pharmacogenetics; 2001 Apr; 11(3):247-54. PubMed ID: 11337940
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
17. [Initial results of glutathione-S-transferase GSTM1 and GSTT1 genotypes and genetic predisposition for laryngeal carcinoma].
Jahnke V; Strange R; Matthias C; Fryer AA
Laryngorhinootologie; 1995 Nov; 74(11):691-4. PubMed ID: 8561822
[TBL] [Abstract][Full Text] [Related]
18. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma.
Lear JT; Smith AG; Heagerty AH; Bowers B; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
Carcinogenesis; 1997 Aug; 18(8):1499-503. PubMed ID: 9276622
[TBL] [Abstract][Full Text] [Related]
19. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
20. Lack of associations of selected variants in genes involved in cell cycle and apoptosis with skin cancer risk.
Han J; Colditz GA; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):592-3. PubMed ID: 16537723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
